Fate Therapeutics Inc
FATE· Nasdaq
Fate Therapeutics Inc
- Last sale
- Oct 1, 2026 · -3.78%
- Market cap
- $274.39M
- 119.82M shares
- Filings
- 848
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $6,646,000 | reported | |
| FY 2024 | 2024-12-31 | $13,631,000 | reported | |
| FY 2023 | 2023-12-31 | $63,533,000 | reported | |
| FY 2022 | 2022-12-31 | $96,300,000 | reported | |
| FY 2021 | 2021-12-31 | $55,846,000 | reported | |
| FY 2020 | 2020-12-31 | $31,434,000 | reported | |
| FY 2019 | 2019-12-31 | $10,680,000 | reported | |
| FY 2018 | 2018-12-31 | $4,740,000 | reported | |
| FY 2017 | 2017-12-31 | $4,106,000 | reported | |
| FY 2016 | 2016-12-31 | $4,402,000 | reported | |
| FY 2015 | 2015-12-31 | $2,431,000 | reported | |
| FY 2013 | 2013-12-31 | $971,000 | reported |
Fate Therapeutics Inc · CIK 1434316 · Engraved from SEC EDGAR
